These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 24583005)
41. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Dong C; Dai X; Meng JH Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900 [TBL] [Abstract][Full Text] [Related]
42. Cloning and expression of cDNAs from hepatitis E virus structural gene. Ruan B; Zumbika E; Wang SY; Chen Y; Ma YL; Chen YG; Liu KZ Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):387-90. PubMed ID: 14599945 [TBL] [Abstract][Full Text] [Related]
43. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002 [TBL] [Abstract][Full Text] [Related]
44. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. McAtee CP; Zhang Y; Yarbough PO; Bird T; Fuerst TR Protein Expr Purif; 1996 Sep; 8(2):262-70. PubMed ID: 8812876 [TBL] [Abstract][Full Text] [Related]
45. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Li SW; Zhang J; Li YM; Ou SH; Huang GY; He ZQ; Ge SX; Xian YL; Pang SQ; Ng MH; Xia NS Vaccine; 2005 Apr; 23(22):2893-901. PubMed ID: 15780738 [TBL] [Abstract][Full Text] [Related]
46. Accurate Identification and Quantification of DNA Species by Next-Generation Sequencing in Adeno-Associated Viral Vectors Produced in Insect Cells. Penaud-Budloo M; Lecomte E; Guy-Duché A; Saleun S; Roulet A; Lopez-Roques C; Tournaire B; Cogné B; Léger A; Blouin V; Lindenbaum P; Moullier P; Ayuso E Hum Gene Ther Methods; 2017 Jun; 28(3):148-162. PubMed ID: 28463571 [TBL] [Abstract][Full Text] [Related]
47. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Zhang Y; McAtee P; Yarbough PO; Tam AW; Fuerst T Clin Diagn Lab Immunol; 1997 Jul; 4(4):423-8. PubMed ID: 9220158 [TBL] [Abstract][Full Text] [Related]
48. Optimization of eGFP expression using a modified baculovirus expression system. Ge J; Jin L; Tang X; Gao D; An Q; Ping W J Biotechnol; 2014 Mar; 173():41-6. PubMed ID: 24445173 [TBL] [Abstract][Full Text] [Related]
49. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques. Huang W; Zhang H; Harrison TJ; Lang S; Huang G; Wang Y J Med Virol; 2008 May; 80(5):824-32. PubMed ID: 18360896 [TBL] [Abstract][Full Text] [Related]
50. [Construction of plasmids expressing hepatitis E virus antigen fragments and their combinations]. Tang H; Ma Y; Li C; Du R; Le G; Zhuang J; Liu Y; Sun M; Dai C Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):562-5. PubMed ID: 12903405 [TBL] [Abstract][Full Text] [Related]
51. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio]. Dong C; Dai X; Meng JH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906 [TBL] [Abstract][Full Text] [Related]
52. Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy. Negrete A; Esteban G; Kotin RM Appl Microbiol Biotechnol; 2007 Sep; 76(4):761-72. PubMed ID: 17680241 [TBL] [Abstract][Full Text] [Related]
53. Improving adeno-associated vector yield in high density insect cell cultures. Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623 [TBL] [Abstract][Full Text] [Related]
54. Impact of dual-baculovirus infection on the Sf9 insect cell transcriptome during rAAV production using single-cell RNA-seq. Virgolini N; Silvano M; Hagan R; Correia R; Alves PM; Clarke C; Roldão A; Isidro IA Biotechnol Bioeng; 2023 Sep; 120(9):2588-2600. PubMed ID: 36919374 [TBL] [Abstract][Full Text] [Related]
56. Prevention of hepatitis E: another step forward. Goel A; Aggarwal R Future Microbiol; 2011 Jan; 6(1):23-7. PubMed ID: 21162633 [TBL] [Abstract][Full Text] [Related]
57. Structure of hepatitis E viral particle. Mori Y; Matsuura Y Virus Res; 2011 Oct; 161(1):59-64. PubMed ID: 21440590 [TBL] [Abstract][Full Text] [Related]
58. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M. Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255 [TBL] [Abstract][Full Text] [Related]
59. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. Mushahwar IK J Med Virol; 2008 Apr; 80(4):646-58. PubMed ID: 18297720 [TBL] [Abstract][Full Text] [Related]
60. [Construction of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes]. Huang X; Shi Z; Wang K; Dang X; Yang P; Yu P Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):807-13. PubMed ID: 18681280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]